Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Invested Capital (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Return on Invested Capital data on record, last reported at 7.47% in Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 738.0% year-over-year to 7.47%; the TTM value through Dec 2025 reached 7.47%, down 738.0%, while the annual FY2025 figure was 23.11%, 2377.0% down from the prior year.
  • Return on Invested Capital reached 7.47% in Q4 2025 per INDV's latest filing, down from 1.08% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.08% in Q4 2024 and bottomed at 7.47% in Q4 2025.